View Press Releases
-
CATO SMS ACQUIRES ARRAY BIOSTATISTICS
CARY, NC - Sep 15, 2020 - For Immediate ReleaseCATO SMS ACQUIRES ARRAY BIOSTATISTICSGlobal Provider Expands Specialized Clinical Research Offering with Enhanced Biostatistical ServicesCARY, Nx
Sep 15, 2020
-
Profacgen Provides Data Analysis Service for Biological Discovery
SHIRLEY, NY, UNITED STATES - Sep 15, 2020 - Profacgen, a state-of-the-art protein service provider based in New York, established its own bioinformatics platform, which has emerged as a very sophisticated scientific infrastructure for bioinformatics involving computational facilities, to help explore, understand and analyze complex biological data in various biotechnological programs and projects
Sep 14, 2020
-
HiFiBiO Therapeutics Announces a Global Strategic Partnership with ABL Bio for the Co-Development of a SARS-CoV-2 Neutralizing Antibody
CAMBRIDGE, MA, UNITED STATES - Sep 14, 2020 - HiFiBiO Therapeutics, a clinical-stage multinational biotherapeutics company focused on the development of novel antibodies in immunomodulation, today announced a partnership agreement with South Korea-based ABL Bio to advance HFB30132A, a SARS-CoV-2 neutralizing antibody for the treatment of COVID-19 patients
Sep 14, 2020
-
WEP Clinical joins with Wren Healthcare to provide home healthcare services
LONDON, UNITED KINGDOM - Sep 14, 2020 - WEP Group Holdings Limited (WEP), a specialist CRO focused on delivering lifesaving drugs to patients that have an unmet clinical need, is expanding its capabilities by making a strategic investment in Wren Healthcare Limited (Wren), a successful and growing clinical nursing healthcare provider in the EU
Sep 14, 2020
-
Check4Cancer launches online service to provide fast cancer screening as thousands of people go untested in the Covid-19 pandemic
CAMBRIDGE, UNITED KINGDOM - Sep 14, 2020 - Check4Cancer, the provider of early cancer detection and genetic services, has launched its new brand and website bringing together all of its cancer services onto one platform
Sep 14, 2020
-
SciBite launches state-of-the-art AI platform for Life Sciences organisations
CAMBRIDGE, UNITED KINGDOM - Sep 11, 2020 - SciBite, the award-winning semantic technology company, today announced the launch of SciBiteAI, a state-of-the-art Artificial Intelligence software platform for leveraging machine learning models alongside semantic technologies to unlock insights into Life Sciences data
Sep 11, 2020
-
Positive Technologies: Vulnerabilities in PAN-OS could threaten internal networks security
FRAMINGHAM, MA, UNITED STATES - Sep 9, 2020 - Palo Alto Networks remediated vulnerabilities in PAN-OS (operating systems version 8.1 or later), which is used by Palo Alto Networks next-generation firewalls (NGFW)
Sep 10, 2020
-
Theratechnologies to Develop Tesamorelin for the Treatment of NASH in the General Population
MONTREAL, QC, CANADA - Sep 10, 2020 - Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, is pleased to announce that it plans to pursue Phase 3 clinical development of tesamorelin for the treatment of Non-Alcoholic Steatohepatitis (NASH) in the general population
Sep 10, 2020
-
Salaso Health’s telemedicine and live exercise platform enable US healthcare teams to stay safely connected with COVID-19 patients
NEW YORK, NY, UNITED STATES - Sep 10, 2020 - In the current pandemic environment, face-to-face physical therapy visits are less viable due to increasing demands on the healthcare system, as well as the enactment of stay-at-home measures and the reticence of patients particularly those from at-risk groups to visit a clinic or hospital setting
Sep 10, 2020
-
Peer-reviewed Study by Optibrium Demonstrates the Value of Deep Learning for Imputation of Drug Discovery Data
CAMBRIDGE, UNITED KINGDOM - Sep 9, 2020 - Optibrium, leading providers of software and services for drug discovery, today announced a peer-reviewed publication, Practical Applications of Deep Learning to Impute Heterogeneous Drug Discovery Data, in the Journal of Chemical Information and Modeling [1]
Sep 10, 2020
-
Dotmatics introduces eln.online to support research start-ups
BISHOP'S STORTFORD, UNITED KINGDOM - Sep 9, 2020 - Dotmatics Ltd, a scientific informatics software and services company that is driving the automation of laboratory data workflows for scientific discovery and innovation research, today announced the introduction of eln
Sep 10, 2020
-
Phosplatin Therapeutics Announces Two Leadership Appointments
NEW YORK, NY - Sep 9, 2020 - Phosplatin Therapeutics, a clinical stage pharmaceutical company focused on oncology therapeutics, today announced the addition to its growing team of Joseph F
Sep 9, 2020
-
MDI Biological Laboratory Scientists Decipher Role of a Stress Response Gene
BAR HARBOR, ME, UNITED STATES - Sep 9, 2020 - Scientists have long known that chronic stress experienced early in life, or even chronic prenatal exposure to maternal stress hormones in the womb, can shorten lifespan and contribute to age-related chronic diseases like arthritis, asthma, cancer, cardiovascular disease, diabetes, heart disease and even mental illness later in life -- long after the source of stress has been removed
Sep 9, 2020
-
ECCRT and IDDI establish partnership for continuous development of IDDI global team members
LOUVAIN-LA-NEUVE, BELGIUM - Sep 9, 2020 - European Centre for Clinical Research Training (ECCRT) has been selected as a premium provider for continuous online learning by IDDI, a BIOSTATISTICAL AND ECLINICAL SERVICES provider for Pharmaceutical and Biotechnology companies
Sep 9, 2020
-
Lifebit Appoints General Manager to Spearhead Global Expansion
LONDON, UK - Sep 8, 2020 - Lifebit Biotech announced today the appointment of Frank Seo, who joins the company as General Manager
Sep 8, 2020
-
DIASORIN AND MEMED PARTNER TO DEVELOP AND COMMERCIALIZE NOVEL HOST IMMUNE RESPONSE BASED DIAGNOSTICS SOLUTION
SALUGGIA, ITALY AND HAIFA, ISRAEL - Sep 8, 2020 - DiaSorin (FTSE MIB: DIA) and MeMed have announced today the creation of a strategic partnership to accelerate the deployment of a novel, host-protein signature-based assay
Sep 8, 2020
-
First-class Chelating Agents Covering Full Range Are Available at CD Bioparticles
SHIRLEY, NY, UNITED STATES - Sep 9, 2020 - Chelating agents are chemical compounds that react with metal ions to form a stable, water-soluble complex
Sep 6, 2020
-
Creative Biolabs Introduces One-Stop CAR-T Preclinical In Vivo Assay Services
SHIRLEY, NY, UNITED STATES - Sep 7, 2020 - Chimeric antigen receptor (CAR) T cell therapy represents the culmination of research in both immunology and oncology fields
Sep 6, 2020
-
Biofourmis Closes $100 Million Series C Funding Round Led by SoftBank Vision Fund 2 to Accelerate U.S. and Global Expansion
BOSTON, MA - Sep 3, 2020 - Biofourmis, a fast-growing global leader in digital therapeutics that powers personalized predictive care, has announced the completion of a $100 million Series C financing round led by SoftBank Vision Fund 2,[1] with participation by existing investors Openspace Ventures, MassMutual Ventures, Sequoia Capital and EDBI
Sep 3, 2020
-
Former FDA Commissioner Dr. Scott Gottlieb to address industry on sustainable innovation at CPhI Festival of Pharma
AMSTERDAM, THE NETHERLANDS - Sep 3, 2020 - : CPhI Festival of Pharma (5-16 October, 2020), the worlds largest ever virtual pharma expo, unveils its ground-breaking two-week long agenda
Sep 3, 2020